Jesús
San Miguel Izquierdo

Consultor Investigador

Foto de Jesús

Foto de Vita-Salute San Raffaele University

Vita-Salute San Raffaele University

Milán, Italia

Publicaciones en colaboración con investigadores/as de Vita-Salute San Raffaele University (2)

2023

Efficacy and safety of isatuximab plus bortezomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma ineligible/with no immediate intent for autologous stem cell transplantation
Leukemia, Vol. 37, Núm. 7, pp. 1521-1529

2022

Corrigendum to “OAB-005: Update of safety and efficacy of Isatuximab short-duration fixed-volume infusion plus Bortezomib, Lenalidomide, and Dexamethasone combined therapy for NDMM ineligible/with no immediate intent for ASCT” [Clinical Lymphoma Myeloma and Leukemia 21 S2 (2021) S3-S4](S2152265021X00122)
Clinical Lymphoma, Myeloma and Leukemia